Related Experiment Videos
[Practical aspects of human rabies prevention]
1Instituto Pasteur, São Paulo, SP, Brazil.
Jornal De Pediatria
|December 20, 2003
Summary
Human rabies cases in Brazil are declining, but post-exposure therapy remains high due to insufficient animal rabies control. Modern vaccines are limited in public health centers, impacting prophylaxis strategies.
Area of Science:
- Public Health
- Epidemiology
- Infectious Diseases
Background:
- Human rabies remains a concern in Brazil, despite a decreasing trend in reported cases since the 1980s.
- Inadequate rabies control programs in animal populations, particularly domestic animals like dogs and cats, contribute to a high demand for post-exposure prophylaxis.
Purpose of the Study:
- To analyze the current rabies situation in Brazil.
- To evaluate the appropriate post-exposure prophylaxis (PEP) for human rabies, considering accident specifics, animal involved, geographic risk, and immunobiologic availability.
Main Methods:
- Bibliographic review of recent literature.
- Analysis of official technical reports from global and Brazilian health authorities (WHO, Brazil Ministry of Health, São Paulo State Department of Health).
Main Results:
- Human rabies cases have decreased since the 1980s.
- High rates of post-exposure therapy are linked to insufficient animal rabies control.
- The Fuenzalida-Palácios vaccine is commonly used; safer, modern vaccines are restricted to private clinics or specific patient groups in public centers.
- Equine rabies immunoglobulin is available and safe, with human rabies immunoglobulin reserved for cases of anaphylaxis risk.
Conclusions:
- While human rabies incidence is declining, the high volume of post-exposure treatments highlights challenges in animal rabies prevention.
- Access to modern, safer rabies vaccines and immunoglobulins in public health settings requires improvement for optimal human rabies prophylaxis.